Navigation Links
Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy
Date:8/21/2014

MISSISSAUGA, ON, Aug. 21, 2014 /CNW/ - Eisai Limited is pleased to support the Canadian Epilepsy Alliance (CEA) in the introduction of the first-of-its-kind comic book available in Canada. The comic book, an innovative educational tool, has been designed specifically to educate children and their parents about epilepsy, the most common neurological disorder in Canada affecting more than 300,000 Canadians. Eisai is guided by a corporate philosophy known as human health care (hhc), in which the patient is central – there was a need within the epilepsy community to help facilitate greater understanding of the disorder for future generations and this certainly aligns with hhc.

"The CEA is always looking for innovative ways to educate Canadians about epilepsy," says Oliver Technow, President and General Manager, Eisai Limited. "Their latest initiative, the MediKidz comic book, takes a unique approach to educating children in a format that resonates, we also know that this will help to inform teachers and parents who may not be familiar with the most common neurological condition in Canada."

Authored by doctors and medical writers, the book's content addresses the mechanics, diagnosis, and treatment of epilepsy and is peer-reviewed by leading medical professionals and endorsed by the Canadian epilepsy community. The MediKidz Explain Epilepsy will be made available through the Canadian Epilepsy Alliance across the country.

About Eisai Limited

Eisai established the Canadian pharmaceutical company Eisai Limited in 2010. As a wholly-owned subsidiary of Eisai Inc., Eisai Limited is based in Mississauga, Ontario, one of the largest biopharmaceutical clusters and medical communities in North America. For more information about Eisai in Canada, please visit www.eisai.ca

About Eisai Inc.

At Eisai Inc., human health care is our goal. We give our first thoughts to patients and their families. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., our passionate commitment to patient care is the driving force. We are a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. To learn more about Eisai Inc., please visit us at www.eisai.com/US

Eisai Inc. has affiliates that are part of a global product creation organization that includes R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as a global demand chain organization that includes manufacturing facilities in Maryland and North Carolina. Eisai's global areas of R&D focus include neuroscience; oncology; metabolic disorders; vascular, inflammatory and immunological reaction; and antibody-based programs.


'/>"/>
SOURCE Eisai Limited
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
2. Eisai Oncology to Present New Research on Eribulin and NEPA at 36th Annual San Antonio Breast Cancer Symposium
3. Eisai Joins Groundbreaking Tuberculosis Drug Accelerator Partnership to Discover New Tuberculosis Drugs
4. Eisai Inc. Announces Non-Exclusive Licensing Agreement with Generic Drug Manufacturer to Provide Generic Version of donepezil HCl 23 mg
5. Eisai Launches New Website Providing Employers with Educational Resource for Obesity Management
6. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
7. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
8. Eisai USA Foundation to Donate $1 Million to the Conquer Cancer Foundation of the American Society of Clinical Oncology
9. Eisai To Sponsor 7th Annual National Walk For Epilepsy To Help Raise Epilepsy Awareness
10. Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
11. FDA Grants Orphan Drug Status To Eisais Lenvatinib
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... January 24, 2017 The global  active pharmaceutical ingredients ... by 2025, based on a new report by Grand View Research, Inc. ... to drive the market over the forecast period. Advancements in recombinant molecular ... to boost growth.  Continue Reading ... ...
(Date:1/24/2017)... 2017 Optoelectronic components have the capability ... interaction of these components with light makes them ... of applications. These components are primarily used in ... healthcare among others. Growing application across ... power consumption, reliability, scalability, and performance is fueling ...
(Date:1/24/2017)... The global peripheral I.V. catheter market accounted ... expected to grow at a CAGR of 6.0% during ... larger share in the global market between the two ... the hospital segment accounted for the highest share in ... peripheral I.V. catheter market is witnessing high growth rate, ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... OMI Industries, a worldwide ... a distribution partnership with Byers Scientific & Manufacturing , a leading designer, ... the agreement, OMI Industries formulated a special version of Ecosorb® for Byers Scientific ...
(Date:1/24/2017)... ... January 24, 2017 , ... Center for Hispanic Leadership ... has named Hector M. Chavez, Manager, Employee & Labor Relations at City of ... its Hispanic Leader of the Month. City of Hope is committed to stay out ...
(Date:1/24/2017)... City, IA (PRWEB) , ... January 24, 2017 , ... ... the country, has taken great care to design a program that provides teachers with ... abroad and domestically. This online teaching certificate is ideal for post-baccalaureate students and HigherEducation.com ...
(Date:1/24/2017)... ... 2017 , ... The NewKILO JRP, a three-year project of the European Metrology ... Union (EU), was completed in May 2015. The future definition will require the unit ... air, which presents some challenges to establishing traceability to the mass scale. , This ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... water, has officially unveiled its latest award-winning bottles, designed specifically to optimize the ... , Taza Agua is renowned for introducing the world’s first untouched bottled ...
Breaking Medicine News(10 mins):